Castle Biosciences CSTL Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's interest coverage?
- Castle Biosciences (CSTL) reported interest coverage of -164× in Q1 2026.
- How has Castle Biosciences's interest coverage changed year-over-year?
- Castle Biosciences's interest coverage decreased by 589.9% year-over-year, from -23.8× to -164×.
- What is the long-term trend for Castle Biosciences's interest coverage?
- Over 5 years (2020 to 2025), Castle Biosciences's interest coverage has grown at a 188.7% compound annual growth rate (CAGR), from -2.5× to -497.8×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.